Bone Diseases, Metabolic

• 

  Subject Areas on Research

  • A note on sample size calculation for mean comparisons based on noncentral t-statistics. 
  • Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. 
  • Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy. 
  • An augmented fixation method for distal fibular fractures in elderly patients: a biomechanical evaluation. 
  • Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. 
  • Association between insulin resistance and bone mass in men. 
  • Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. 
  • Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021. 
  • CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. 
  • Changes in bone health and skeletal-related events following implementation of a multidisciplinary consensus statement guiding surveillance and treatment of men undergoing androgen deprivation therapy for prostate cancer. 
  • Comparison of computed tomography and 3D magnetic resonance imaging in evaluating glenohumeral instability bone loss. 
  • Conditional estimation for generalized linear models when covariates are subject-specific parameters in a mixed model for longitudinal measurements. 
  • Current practices in nutrition management and disease incidence of common marmosets (Callithrix jacchus). 
  • Diagnosis and management of mineral metabolism in CKD. 
  • Does this woman have osteoporosis? 
  • Drug-induced bone disease. 
  • Effect of antiepileptic drugs on bone density in ambulatory patients. 
  • Effects of perinatal alcohol exposure and dietary calcium supplements on skeletal and dental growth in rats. 
  • Frequency of abnormal hand and wrist radiographs at time of diagnosis of polyarticular juvenile rheumatoid arthritis. 
  • How much vitamin D should I take? 
  • Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). 
  • Long-term risk of medical conditions associated with breast cancer treatment. 
  • Medication discontinuation after curative surgery for sporadic primary hyperparathyroidism. 
  • Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. 
  • Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy. 
  • Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we? 
  • Primary biliary cirrhosis: new therapeutic directions. 
  • Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. 
  • Racial and ethnic differences in physical activity and bone density: National Health and Nutrition Examination Survey, 2007-2008. 
  • Repair of osteopenia in children with juvenile rheumatoid arthritis. 
  • Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. 
  • Should there be a fracas over FRAX and other fracture prediction tools?: Comment on "A comparison of prediction models for fractures in older women". 
  • Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy. 
  • The assessment of bone mineral content and density of the lumbar spine and proximal femur in US submariners. 
  • The beehive and the merry-go-round in mineral metabolism. 
  • The emerging phenotype of long-term survivors with infantile Pompe disease. 
  • The evaluation of pelvic injury in the female athlete. 
  • The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. 
  • The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. 
  • Update on the use of distal radial bone density measurements in prediction of hip and Colles' fracture risk. 
  • What is the clinical significance of bone loss in primary hyperparathyroidism? 
• 

  Keywords of People

  • Case, Laura Elizabeth, Associate Professor in Orthopaedic Surgery, Pediatrics, Medical Genetics
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics